Nia Tatsis, Ph.D.
Executive Vice President and Chief Regulatory and Quality Officer
Nia has extensive experience in global regulatory affairs in the pharmaceutical industry. She joined Vertex in 2017, and she provides global regulatory leadership and manages all regulatory interactions and quality assurance involving the research and development, manufacturing and commercialization of our medicines. In addition to creating and executing the company’s global regulatory strategy, Nia also manages a worldwide team of regulatory professionals.
She graduated with a B.S. in biology from Temple University and a Ph.D. in cell and molecular biology from the University of Vermont. Before joining Vertex, she held positions of increasing responsibility at pharmaceutical companies such as Sanofi, Stemnion, Pfizer and Wyeth.
In addition to her responsibilities at Vertex, Nia serves on the board of directors for Verve Therapeutics. In 2024, she was named to the Endpoints News Women Leading Biopharma R&D list and the PharmaVoice 100. She was previously named to Fierce Pharma's Fiercest Women in Life Sciences list.
Nia has extensive experience in global regulatory affairs in the pharmaceutical industry. She joined Vertex in 2017, and she provides global regulatory leadership and manages all regulatory interactions and quality assurance involving the research and development, manufacturing and commercialization of our medicines. In addition to creating and executing the company’s global regulatory strategy, Nia also manages a worldwide team of regulatory professionals.
She graduated with a B.S. in biology from Temple University and a Ph.D. in cell and molecular biology from the University of Vermont. Before joining Vertex, she held positions of increasing responsibility at pharmaceutical companies such as Sanofi, Stemnion, Pfizer and Wyeth.
In addition to her responsibilities at Vertex, Nia serves on the board of directors for Verve Therapeutics. In 2024, she was named to the Endpoints News Women Leading Biopharma R&D list and the PharmaVoice 100. She was previously named to Fierce Pharma's Fiercest Women in Life Sciences list.